Swiss Startup Investments - Weekly recap (10.04.-14.04.2023) - Week #15
The second week of Apr ‘23 features 8 startups and 2 exits. Who plans to invest in GenAI startups in the next 6 months?
Hey there,
Great news! The newsletter has officially surpassed the 500 subscriber milestone. As I promised on LinkedIn, I will be sending an invitation to our 500th subscriber very soon.
Lately, my social media feeds have been inundated with discussions about GenAI technologies and tools such as ChatGPT, AutoGPT, BabyGPT, and many others. For those interested in investing in this field, I have a quick poll for you:
Don’t forget to register to the upcoming Digital Health Cocktail Hours at ETH AI Center: Enabling Digital Health innovation with AI & ML - 27th of April.
Thank you all for your continued support!
Gian
Biotech
Alentis Therapeutics: $105M - Series C
Mosanna Therapeutics: Undisclosed - Seed
Araris Biotech: Undisclosed
Cleantech
Xilva: $1.8M - Pre-Seed
Neology Hydrogen: CHF 100k - Convertible Loan
Engineering
Irmos Technologies: CHF 150k - Convertible Loan
Foodtech
Yumame Foods: Undisclosed - Pre-Seed
Materials
a-metal: CHF 100k - Convertible Loan
—
Exit
Surs GmbH acquires Elephbo
Pocket Bitcoin acquires Kipi Technologies
—
Swisspreneur Podcast
Listen to Pascale Vonmont, director of the Gebert Rüf Stiftung: Foundations in Switzerland - EP #313
—
News & events
Welcome to all the new subscribers! If you like this newsletter, forward it to your contacts!